Association of serum copper levels and glycemic control in patients with type 2 diabetes

Endocrine Journal

Volumn 60, Issue 3, 2013, Pages 393-396

  Naka, Toyoko ^a   Kaneto, Hideaki ^a   Katakami, Naoto ^a   Matsuoka, Taka Aki ^a   Harada, Ayako ^a   Yamasaki, Yoshimitsu ^a   Matsuhisa, Munehide ^b   Shimomura, Iichiro ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Copper; Hemoglobin A1c (HbA1c); Type 2 diabetes

Indexed keywords

COPPER; HEMOGLOBIN A1C;

ADULT; ATOMIC ABSORPTION SPECTROMETRY; COPPER BLOOD LEVEL; DIABETES CONTROL; DISEASE ASSOCIATION; FEMALE; GLYCEMIC CONTROL; HEMOGLOBIN DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; OUTCOME ASSESSMENT;

AGED; BLOOD GLUCOSE; COPPER; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED;

EID: 84875886784     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.EJ12-0342     Document Type: Note

References (15)

1. Uriu-Adams JY, Keen CL (2005) Copper, oxidative stress, and human health. Mol Aspects Med 26: 268-298.
2. Goodman VL, Brewer GJ, Merajver SD (2005) Control of copper status for cancer therapy. Curr Cancer Drug Targets 7: 543-549.
3. Walshe JM (2007) Cause of death in Wilson disease. Mov Disord 22: 2216-2220.
4. Hunt JV, Smith CC, Wolff SP (1990) Autoxidative glycosylation and possible involvement of peroxides and free radicals in LDL modification by glucose. Diabetes 39: 1420-1424.
5. Kobayashi K, Watanabe J, Umeda F, Nawata H (1995) Glycation accelerates the oxidation of low density lipoprotein by copper ions. Endocr J 42: 461-465.
6. Xie H, Kang YJ (2009) Role of copper in angiogenesis and its medicinal implications. Curr Med Chem 16: 1304-1314.
7. Tanaka A, Kaneto H, Miyatsuka T, Yamamoto K, Yoshiuchi K, et al. (2009) Role of copper ion in the pathogenesis of type 2 diabetes. Endocr J 56: 699-706.
8. Chausmer AB (1998) Zinc, insulin and diabetes. J Am Coll Nutr 17: 109-115.
9. Champagne CM (2008) Magnesium in hypertension, cardiovascular disease, metabolic syndrome and other conditions: a review. Nutr Clin Pract 23: 142-151.
10. Soinio M, Marniemi J, Laakso M, Pyorala K, Lehto S, et al. (2007) Serum zinc level and coronary heart disease events in patients with type 2 diabetes. Diabetes Care 30: 523-528.
11. DiSilvestro RA (2000) Zinc in relation to diabetes and oxidative disease. J Nutr 130: 1509S-1511S.
12. Walter RM, Uriu-Hare JY, Olin KL, Oster MH, Anawalt BD, et al. (1991) Copper, zinc, manganese and magnesium status and complications of diabetes mellitus. Diabetes Care 14: 1050-1056.
13. Gums JG (2004) Magnesium in cardiovascular and other disorders. Am J Health Syst Pharm 61: 1569-1576.
14. Viktorinova A, Toserova E, Krizko M, Durackova Z (2009) Altered metabolism of copper, zinc, and mag-- nesium is associated with increased levels of glycated hemoglobin in patients with diabetes mellitus. Metabolism 58: 1477-1482.
15. Ookawara T, Kawamura N, Kitagawa Y, Taniguchi N (1992) Site-specific and random fragmentation of Cu,Zn-superoxide dismutase by glycation reaction. Implication of reactive oxygen species. J Biol Chem 267: 18505-18510.